Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.
NCT05408481 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-06-07
Summary
Hyponatremia in COVID-19 patients with adrenal insufficiency
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Serum cortisol level
Biochemical test
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 19 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-30
- Primary Completion
- 2022-12-31
- Completion
- 2023-03-31
More Related Trials
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
NCT02399358 ·Status: UNKNOWN
-
Saline Infusion Test in Hyponatremia
NCT06498856 ·Status: NOT_YET_RECRUITING
-
Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients
NCT01456533 ·Status: COMPLETED
-
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
NCT00860340 ·Status: COMPLETED ·Phase: NA
-
Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human
NCT02129621 ·Status: COMPLETED ·Phase: NA
-
Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia
NCT04744987 ·Status: COMPLETED
-
Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
NCT05411991 ·Status: COMPLETED ·Phase: PHASE4
-
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT05925569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Water Load Test Value for Hyponatremia
NCT04256499 ·Status: COMPLETED
-
New Screening and Diagnostic Cut-off Points of PA Patients
NCT06571084 ·Status: RECRUITING
-
Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia
NCT03557957 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia
NCT01850940 ·Status: COMPLETED
-
Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia
NCT01507727 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism
NCT05649631 ·Status: COMPLETED ·Phase: NA
-
Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels
NCT01614860 ·Status: COMPLETED
-
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575 ·Status: COMPLETED ·Phase: PHASE3
-
Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
NCT00324883 ·Status: COMPLETED
-
Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients
NCT03658850 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
NCT06164379 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)
NCT00843986 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
NCT03351283 ·Status: COMPLETED ·Phase: NA
-
Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension
NCT00005394 ·Status: COMPLETED
-
A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers
NCT01314898 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
NCT01468571 ·Status: UNKNOWN ·Phase: PHASE4